The clinical research industry has experienced a seismic shift over the past few years, from the pandemic to decentralised trials to technological innovations.
The UK is welcoming a new era of clinical trial delivery, evolving beyond the traditional site-centric approach to also embrace remote, decentralised, virtual, and hybrid trials and enablin